A company still losing money, with high risk.
Facts from SEC filings, not a recommendation.
From AMOD's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: -$11.1M, down from a positive year before.
Move the sliders to your own view of AMOD. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 10 bought, 0 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page